<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="healthcare-08-00204-t006" orientation="portrait" position="float">
 <object-id pub-id-type="pii">healthcare-08-00204-t006_Table 6</object-id>
 <label>Table 6</label>
 <caption>
  <p>Studies on the design of antiviral agents based on the structure and function of viral and human receptor proteins (Sub-Cluster 2-2).</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">NO</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organization</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Title</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Estimated Average Cost/Fiscal Year (USD)</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Estimated Total Cost (USD)</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Start Date</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">End Date</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Geographic Region </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">University of North Carolina Chapel Hill</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,310,955</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,554,775</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 August 2017</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 July 2022</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">University of Alabama at Birmingham</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitors of coronavirus fidelity and cap methylation as broadly applicable</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">996,397</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4,981,985</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 March 2014</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28 February 2019 </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kansas State University</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small molecule protease inhibitors against MERS-CoV</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">775,916</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,879,580</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 May 2018</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 April 2023</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The Johns Hopkins University</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Applying human factors and mathematical modeling approaches to prevent transmission of high consequence pathogens</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,222,700</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,668,100</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 September 2015</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29 September 2018</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">US</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nippon Veterinary and Life Science University</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The development of specific anti coronavirus drugs using the novel glycosidase inhibitors</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48,100</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144,300</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 April 2016</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 March 2019</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">JP</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
